Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 729-734

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Kim, Won ^a   Kim, Yoon Jun ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver function; Lymph node metastasis; Radiotherapy; Symptoms

Indexed keywords

BIOLOGICALLY EFFECTIVE DOSE; CLASS B; DISTANT METASTASIS; FALSE DISCOVERY RATE; FRACTION SIZE; HEPATOCELLULAR CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; MEDIAN SURVIVAL; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSTIC FACTORS; RADIATION DOSE; RISK FACTORS; SYMPTOMS; UNIVARIATE ANALYSIS; UP PERIOD;

BODY FLUIDS; LIVER; MULTIVARIANT ANALYSIS; RADIOTHERAPY;

PATHOLOGY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SURVIVAL TIME; SYMPTOM; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; LIVER; LIVER NEOPLASMS; LYMPH NODE DISSECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION DOSE; RELATIVE BIOLOGIC EFFECTIVENESS; REMISSION; SECONDARY; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; REMISSION INDUCTION; SURVIVAL RATE; TUMOR BURDEN;

EID: 77957204834     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.047     Document Type: Article

References (27)

1. Z.C. Zeng, Z.Y. Tang, and B.H. Yang Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial Hepatogastroenterology 51 2004 201 207
2. Z.C. Zeng, Z.Y. Tang, and J. Fan Consideration of radiotherapy for lymph node metastases in patients with HCC: Retrospective analysis for prognostic factors from 125 patients Int J Radiat Oncol Biol Phys 63 2005 1067 1076
3. Y.J. Park, D.H. Lim, and S.W. Paik Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma J Gastroenterol 41 2006 1099 1106
4. H. Yamashita, K. Nakagawa, and K. Shiraishi Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: Retrospective study J Gastroenterol Hepatol 22 2007 523 527 (Pubitemid 46434969)
5. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
6. J.W. Park Practice guideline for diagnosis and treatment of hepatocellular carcinoma Korean J Hepatol 10 2004 88 98
7. E.L. Kaplan, and P.I. Meier A nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
8. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: A practical and powerful approach to multiple testing J R Stat Soc Ser B 57 1995 289 300
9. H. Beck-Bornholdt, and H. Dubben Potential pitfalls in the use of p-values and in interpretation of significance levels Radiother Oncol 33 1994 171 176
10. H.C. Sun, P.Y. Zhuang, and L.X. Qin Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy J Surg Oncol 96 2007 37 45
11. G. Ercolani, G.L. Grazi, and M. Ravaioli The role of lymphadenectomy for liver tumors: Further considerations on the appropriateness of treatment strategy Ann Surg 239 2004 202 209
12. J. Watanabe, O. Nakashima, and M. Kojiro Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: A retrospective study of 660 consecutive autopsy cases Jpn J Clin Oncol 24 1994 37 41
13. J. Kaczynski, G. Hansson, and S. Wallerstedt Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor: An autopsy study from a low endemic area Acta Oncol 34 1995 43 48
14. T. Uenishi, K. Hirohashi, and T. Shuto The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma Surg Today 30 2000 892 895
15. Y. Une, K. Misawa, and T. Shimamura Treatment of lymph node recurrence in patients with hepatocellular carcinoma Surg Today 24 1994 606 609
16. J. Dancey, B. Zee, and D. Osoba Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy: The National Cancer Institute of Canada Clinical Trials Group Qual Life Res 6 1997 151 158
17. G.I. Ringdal, K.G. Götestam, and S. Kaasa Prognostic factors and survival in a heterogeneous sample of cancer patients Br J Cancer 73 1996 1594 1599
18. A. Coates, F. Porzsolt, and D. Osoba Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy Eur J Cancer 33 1997 1025 1030
19. W. Yeo, F.K. Mo, and J. Koh Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma Ann Oncol 17 2006 1083 1089
20. T. Leung, A. Tang, and B. Zee Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system Cancer 94 2002 1760 1769
21. K. Okuda, T. Ohtsuki, and H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients Cancer 56 1985 918 928
22. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients Hepatology 28 1998 751 755
23. J.M. Llovet, C. Brú, and J. Bruix Prognosis of hepatocellular carcinoma: The BCLC staging classification Semin Liver Dis 19 1999 329 338
24. A. Nanashima, Y. Sumida, and T. Abo Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy J Gastroenterol 41 2006 250 256
25. Y.H. Huang, C.H. Chen, and T.T. Chang Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery J Gastroenterol Hepatol 20 2005 765 771
26. J. Seong, S.J. Shim, and I.J. Lee Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy Int J Radiat Oncol Biol Phys 67 2007 1037 1042
27. A.L. Cheng, Y.K. Kang, and Z. Chen Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34